Trial intelligence / Profile preview

Torasemide in UMOD-stratified hypertension

NCT03354897Phase 4Completed

Sponsor
NHS Greater Glasgow and Clyde
Start
Apr 2017
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of torasemide in hypertension (HTN), sponsored by NHS Greater Glasgow and Clyde. Started Apr 2017; status: completed.

02

Drugs

torasemide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT03354897.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03354897.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call